Ignite Creation Date:
2025-12-25 @ 1:41 AM
Ignite Modification Date:
2026-03-01 @ 10:11 AM
Study NCT ID:
NCT01767194
Status:
COMPLETED
Last Update Posted:
2022-10-24
First Post:
2013-01-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-02-12
Start Date Type:
ACTUAL
Primary Completion Date:
2018-06-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-30
Completion Date Type:
ACTUAL
First Submit Date:
2013-01-09
First Submit QC Date:
None
Study First Post Date:
2013-01-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-06-24
Results First Submit QC Date:
None
Results First Post Date:
2019-11-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-21
Last Update Post Date:
2022-10-24
Last Update Post Date Type:
ACTUAL